Haemonetics Corporation Price to Earnings Ratio (PE) Ratios, (HAE) Valuation Ranking and Trends, Fundamental Ratios - CSIMarket
CSIMarket
 




Haemonetics Corporation  (NYSE: HAE)
 





HAE Price to Earnings Ratio Current (Dec 27 2025) (Sep 27 2025) (Jun 28 2025) (Mar 29 2025)
Diluted EPS 12 Trailing Months III. Quarter II. Quarter I. Quarter IV. Quarter
PE (TTM) Ratio current            52.14            18.66            18.26            20.44            20.74
Diluted EPS TTM Y / Y Change -38.11 % 41.73 % 40.66 % 45.29 % 43.23 %
Diluted EPS Y / Y Change - % 28.38 % 22.73 % -5.41 % 185 %
Stock performance to date 32.35 % 64.21 % -36.14 % 18.39 % -18.94 %

Price to earnings ratio Comment
Haemonetics Corporation's current Price to earnings ratio has increased due to shareprice growth of 32.35 %, from beginning of IV. Quarter and due to eps contraction of 0 %, to Pe of 52.14, from average Price to earnings ratio in III. Quarter of 18.66.

Within Healthcare sector 196 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Haemonetics Corporation Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #59
Sector #197
S&P 500 #2161





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.